olmesartan medoxomil

olmesartan medoxomil (BENICAR) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

BENICAR is a marketed brand name for olmesartan medoxomil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

olmesartan medoxomil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.